Headlines
- Wedbush updates earnings projections for Perspective Therapeutics
- Company shows slight earnings improvement despite losses
- Multiple analysts offer positive outlook on stock performance
Wedbush (NYSE:WFC) has recently provided insights into the earnings projections for Perspective Therapeutics. In a research note, it was anticipated that the company would report a quarterly loss. The consensus estimate for the company's earnings for the current fiscal year suggests a similar trend, reflecting ongoing challenges.
In their latest forecast, Wedbush estimated the upcoming quarterly earnings, along with projections extending to fiscal years beyond. Perspective Therapeutics (NYSE:CATX) previously announced its earnings, showing a small increase compared to earlier expectations.
Additionally, various equity analysts have expressed their views on Perspective Therapeutics. Oppenheimer revised its price target, while Bank of America initiated coverage, reflecting optimism about the company’s potential. Cantor Fitzgerald maintained a favorable stance, and Royal Bank of Canada adjusted its price objective but still retains a positive outlook. Truist Financial also entered coverage, underscoring confidence in the company.
With multiple analysts recognizing the company’s capabilities, Perspective Therapeutics has garnered a favorable rating from a majority of industry analysts, indicating a positive sentiment surrounding its future performance.